Price T Rowe Associates Inc Exact Sciences Corp Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,703,265 shares of EXAS stock, worth $153 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,703,265
Previous 6,403,872
42.17%
Holding current value
$153 Million
Previous $277 Million
29.01%
% of portfolio
0.02%
Previous 0.03%
Shares
19 transactions
Others Institutions Holding EXAS
# of Institutions
648Shares Held
157MCall Options Held
1.43MPut Options Held
2.3M-
Capital World Investors Los Angeles, CA18.2MShares$754 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$742 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$500 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$497 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$223 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.33B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...